Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exemestane vs Placebo After 5 Years of Tamoxifen in Early Breast Cancer
NCT00016432Phase 3Completed
- Sponsor
- NSABP Foundation
- Start
- May 2001
- Primary completion
- Oct 2003
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 3, randomised, double-blind trial in breast cancer comparing Exemestane with Placebo (2 arms). Primary endpoint: Disease-Free Survival. Started May 2001; status: completed.
02
Drugs
exemestane
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00016432.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00016432.